KR100717361B1 - Method of preparing racemic tolterodine and its intermediate - Google Patents

Method of preparing racemic tolterodine and its intermediate Download PDF

Info

Publication number
KR100717361B1
KR100717361B1 KR1020060074233A KR20060074233A KR100717361B1 KR 100717361 B1 KR100717361 B1 KR 100717361B1 KR 1020060074233 A KR1020060074233 A KR 1020060074233A KR 20060074233 A KR20060074233 A KR 20060074233A KR 100717361 B1 KR100717361 B1 KR 100717361B1
Authority
KR
South Korea
Prior art keywords
phenylpropyl
iodide
methylphenyl
represented
tolterodine
Prior art date
Application number
KR1020060074233A
Other languages
Korean (ko)
Inventor
김경수
박영준
이종협
Original Assignee
주식회사 카이로제닉스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 카이로제닉스 filed Critical 주식회사 카이로제닉스
Priority to KR1020060074233A priority Critical patent/KR100717361B1/en
Application granted granted Critical
Publication of KR100717361B1 publication Critical patent/KR100717361B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

본 발명은 하기 화학식 (I)로 표시되는 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민('톨테로딘 라세미체'라고도 함)을 제조하는 방법에 관한 것으로, 6-메틸-4-페닐-3,4-디히드로쿠마린을 환원시켜 개환하고, 얻어진 화합물을 메탄술포닐화하고, 요오드화염과 N,N-디이소프로필아민을 연속으로 반응시키고, 얻어진 화합물을 가수분해하여 톨테로딘 라세미체를 고순도로 용이하게 제조하기 위한 방법이다. The present invention provides N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine (also referred to as 'tolterodine racemate') represented by the following general formula (I) It relates to a method of reducing, 6-methyl-4-phenyl-3,4-dihydrocoumarin is reduced by ring opening, the obtained compound is methanesulfonyl, and the iodide salt and N, N-diisopropylamine are continuously reacted. It is a method for producing tolterodine racemate easily and with high purity by hydrolyzing the obtained compound.

Figure 112006056397066-pat00001
Figure 112006056397066-pat00001

톨테로딘, 톨테로딘 라세미체, N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민, (R)-N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민, 6-메틸-4-페닐-3,4-디히드로쿠마린, 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르 Tolterodine, tolterodine racemate, N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine, (R) -N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine, 6-methyl-4-phenyl-3,4-dihydrocoumarin, methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl ) -4-methylphenyl ester

Description

톨테로딘 라세미체 및 이의 중간체의 제조방법{Method of Preparing Racemic Tolterodine and Its Intermediate}Method for preparing tolterodine racemates and intermediates thereof Method of Preparing Racemic Tolterodine and Its Intermediate

본 발명은 톨테로딘 라세미체 및 이의 중간체의 제조방법에 관한 것이다. 보다 구체적으로, 본 발명은 화학식 (II)로 표시되는 무스카린 수용체 길항제인 (R)-N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민(톨테로딘)의 핵심 중간체인 화학식 (I)로 표시되는 톨테로딘 라세미체 및 이의 중간체인 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르의 새로운 제조방법에 관한 것이다. The present invention relates to a process for preparing tolterodine racemates and intermediates thereof. More specifically, the present invention relates to (R) -N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine, which is a muscarinic receptor antagonist represented by the formula (II) ( New preparation method of tolterodine racemate represented by formula (I) which is a core intermediate of tolterodine) and methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenyl ester thereof It is about.

Figure 112006056397066-pat00002
Figure 112006056397066-pat00003
Figure 112006056397066-pat00002
Figure 112006056397066-pat00003

요실금이라 불리는 증상은 자신의 의지와 상관없이 요도를 통해 소변이 나오는 증상으로서, 상당수의 성인인구가 요실금으로 고생하고 있다. 특히 절박성 요실 금은 방광이 과도하게 활성화되어 방광에 소변이 채워지는 동안 방광의 근육막을 형성하는 평활근 섬유다발 수축이 정상적으로 제어되지 못하여 발생하는 것으로 추측된다. 최근에 개발된 톨테로딘은 빈뇨, 절박뇨 또는 절박성 요실금과 같은 과활동성 방광에 대한 우수한 치료 효과가 있다는 임상 결과가 발표됨에 따라 이의 치료제로 주목받고 있다. Urinary incontinence is a condition in which urine flows out of the urethra regardless of one's intention. In particular, urge urinary incontinence is thought to be caused by uncontrolled smooth muscle fiber bundle contraction, which forms the muscle membrane of the bladder while the bladder is excessively activated to fill the bladder with urine. The recent development of tolterodine has attracted attention as a therapeutic agent for it, with clinical results showing that there is an excellent therapeutic effect on overactive bladder such as urinary, urgency, or urinary incontinence.

톨테로딘 또는 이의 유사체들의 제조 방법은 미국 특허 제5382600호(Pharmacia Aktiebolag), 대한민국 특허 제0463614호(Pharmacia & Upjohn Company) 및 미국 특허출원 제2001/0016669호(Pher G. Andersson) 등에 개시되어 있다. Methods for preparing tolterodine or analogs thereof are disclosed in US Pat. No. 5,538,600 (Pharmacia Aktiebolag), Korean Patent No. 0463614 (Pharmacia & Upjohn Company), and US Patent Application 2001/0016669 (Pher G. Andersson).

상기 문헌에 개시된 톨테로딘의 제조 방법들을 요약하면 다음과 같다. The method for preparing tolterodine disclosed in the above document is summarized as follows.

미국 특허 제5382600호는 톨테로딘의 초기 제조방법으로서, 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 개환 반응시키고, 리튬알루미늄히드리드로 환원시키고, 알코올을 토실화하고, 디이소프로필아민과 반응시키고, 디메틸화하여 톨테로딘 라세미체를 제조하는 방법이다. 이때 얻어진 톨테로딘 라세미체는 L(+)-타타릭산으로 단리하여 화학식 (II)으로 표시되는 순수한 톨테로딘을 제조한다(하기 반응식 1 참조). 이 방법은 반응단계가 매우 많고 고압의 반응공정을 사용할 뿐만 아니라 대량합성공정에서 사용하기 어려운 시약(예: 리튬알루미늄히드리드, 트리브로모보레인 등) 들이 다수 사용되는 문제점이 있다. U.S. Pat.No. 5,526,600 is an initial method for preparing tolterodine, which ring-opens and reacts 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by the formula (III) with a lithium aluminum hydride. Is tosylated, reacted with diisopropylamine, and dimethylated to prepare tolterodine racemate. The tolterodine racemate obtained at this time is isolated by L (+)-tatariic acid to prepare pure tolterodine represented by the formula (II) (see Scheme 1 below). This method has a problem in that there are many reaction steps and a high pressure reaction process, as well as a number of reagents (eg, lithium aluminum hydride, tribromoborane, etc.) which are difficult to use in a mass synthesis process.

반응식 1Scheme 1

Figure 112006056397066-pat00004
Figure 112006056397066-pat00004

대한민국 특허 제0463614호의 제조방법은 미국 특허 제5382600호를 개량한 방법으로 하기 반응식 2에 나타낸 바와 같이 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 환원시켜 상응하는 알코올인 3,4-디히드로-6-메틸-4-페닐-2H-벤조피린-2-올을 제조하고, 상기 알코올을 이소프로필아민과 반응시키고, 형성된 라세미체를 분리하여 화학식 (II)로 표시되는 톨테로딘을 제조한다(하기 반응식 2 참조). 이 방법은 반응식 1의 공정보다 개선된 방법으로 반응공정이 대폭 단 축되었으나 대량합성공정에 사용하기 어려운 디이소부틸 알루미늄히드리드와 같은 시약이나 수소반응을 사용해야하는 문제점이 있다. The method of preparing Korean Patent No. 0463614 is an improved method of US Pat. No. 5,538,600 to reduce 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by Formula (III) as shown in Scheme 2 below. A corresponding alcohol, 3,4-dihydro-6-methyl-4-phenyl-2H-benzopylin-2-ol, was prepared, the alcohol was reacted with isopropylamine, and the racemates formed were separated Tolterodine represented by II) is prepared (see Scheme 2 below). This method is an improvement over the process of Scheme 1, but the reaction process is greatly shortened, but there is a problem in that a reagent such as diisobutyl aluminum hydride or hydrogen reaction, which is difficult to use in a mass synthesis process, must be used.

반응식 2Scheme 2

Figure 112006056397066-pat00005
Figure 112006056397066-pat00005

미국특허 제2001/0016669호에서는 5-메틸-3-페닐-인데-1-온을 (R)-MeCBS 촉매를 사용하여 카보닐기를 비대칭으로 환원시키고, DABCO를 이용하여 5-메틸-3-(S)-페닐-인단-1-온을 제조하고, mCPBA를 이용하여 6-메틸-4-(S)-페닐-3,4-디히드로쿠마린을 제조하고, 이를 환원시키고, 얻어진 알코올을 디이소프로필아민과 반응시켜 화학식 (II)로 표시되는 톨테로딘을 제조한다(하기 반응식 3 참조). 이 반응은 반응식 1 또는 반응식 2에 개시된 반응과 같이 마지막 단계에서 이성질체를 분 리하는 대신에 비대칭 환원반응으로 원하는 이성질체만을 만들 수 있다는 점에서 장점이 있으나 합성공정이 많이 늘어나고 대량합성공정에서 사용하기 어려운 시약이나 반응이 다수 사용되어야 하는 문제점을 가지고 있다. U.S. Patent No. 2001/0016669 discloses that 5-methyl-3-phenyl-in-1-one is asymmetrically reduced to a carbonyl group using (R) -MeCBS catalyst, and 5-methyl-3- (using DABCO). S) -phenyl-indan-1-one was prepared, and 6-methyl-4- (S) -phenyl-3,4-dihydrocoumarin was prepared using mCPBA, and the obtained alcohol was reduced to diiso. Reacting with propylamine to prepare tolterodine represented by the formula (II) (see Scheme 3 below). This reaction is advantageous in that it can produce only the desired isomer by asymmetric reduction instead of separating the isomer in the last step like the reaction described in Scheme 1 or Scheme 2, but the synthesis process is increased and it is difficult to use in the mass synthesis process. There are problems that many reagents or reactions must be used.

반응식 3Scheme 3

Figure 112006056397066-pat00006
Figure 112006056397066-pat00006

이에 본 발명자들은 상기와 같은 공지 기술의 문제점을 해결하여 보다 단순하고 용이한 공정으로 톨테로딘을 제조하기 위하여 연구를 계속한 결과, 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 리튬보로히드리드와 반응 시켜 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐프로필)-4-메틸페놀을 제조하고, 이를 메탄술포닐 클로라이드 및 트리에틸아민을 반응시켜 화학식 (V)로 표시되는 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르를 제조하고, 상기 화합물 (V)을 요오드화염과 N,N-디이소프로필아민을 순차적으로 반응시켜 화학식 (VI)으로 표시되는 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르를 제조하고, 상기 화합물 (VI)을 수용성용매 및 물의 혼합용매에서 수산화염을 반응시켜 화학식 (I)로 표시되는 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민을 높은 수율로 용이하게 합성할 수 있다는 사실을 알아내었다. Accordingly, the present inventors have continued to research to produce tolterodine in a simpler and easier process by solving the problems of the known technology as described above, 6-methyl-4-phenyl-3, represented by the formula (III), 4-dihydrocoumarin is reacted with lithium borohydride to prepare 2- (3-hydroxy-1-phenylpropyl) -4-methylphenol represented by formula (IV), which is methanesulfonyl chloride and tri Ethylamine was reacted to prepare methanesulphonic acid 3- (2-methanesulfoxy-5-methylphenyl) -3-phenylpropyl ester represented by the formula (V), and the compound (V) was reacted with an iodide salt and N, N -Diisopropylamine was reacted sequentially to prepare methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenyl ester represented by the formula (VI), and the compound (VI) Reaction of the hydroxide salt in a mixed solvent of water-soluble solvent and water to formula (I) Found out the fact that the display N, N- diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropan amine in a high yield can readily be synthesized.

즉, 본 발명자들은 미국 특허 제5382600호에 기재된 방법과 출발물질은 동일하지만, 페놀기의 보호기 도입반응을 별도로 수행하지 않을 뿐만 아니라 대량합성공정에서 사용하기 어려운 고압의 반응공정을 사용하지 않고 N,N-디이소프로필아민을 효과적으로 도입하는 공정을 이용함으로써 기존의 톨테로딘 라세미체 합성공정을 획기적으로 개선하였다. That is, the inventors of the present invention are the same as the starting material described in US Pat. No. 5,538,600, but do not separately perform the protecting group introduction reaction of the phenol group, and do not use a high-pressure reaction process that is difficult to use in a mass synthesis process, N, By using a process for effectively introducing N-diisopropylamine, the existing tolterodine racemate synthesis process has been drastically improved.

본 발명에 따르면, 수분과 접촉시 화재를 유발하는 시약, 유독성 기체를 발생하는 시약, 또는 고압의 수소를 사용하지 않으며, 고압의 반응공정을 사용하지 않으면서도 반응공정이 단축된 새로운 공정으로 고품질의 화학식 (I)로 표시되는 톨테로딘 라세미체를 제조할 수 있다. According to the present invention, a reagent which causes a fire when contacted with moisture, a reagent that generates a toxic gas, or a high-pressure hydrogen is not used, and the reaction process is shortened without using a high-pressure reaction process. Tolterodine racemate represented by general formula (I) can be manufactured.

본 발명의 목적은 요실금의 치료에 우수한 효과를 나타내는 무스카린 수용체 길항제인 (R)-N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민(톨테로딘)의 핵심중간체인 톨테로딘 라세미체의 새로운 제조방법을 제공하는 것이다.An object of the present invention is (R) -N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine (tolte), which is a muscarinic receptor antagonist with excellent effect in the treatment of urinary incontinence. It is to provide a new method for preparing tolterodine racemate, a core intermediate of Rodin).

본 발명의 다른 목적은 톨테로딘 라세미체를 제조하는 공정을 이용하여 간단하게 톨테로딘 라세미체의 중간체인 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르를 제조하는 것이다.Another object of the present invention is simply methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenyl which is an intermediate of tolterodine racemate using a process for preparing tolterodine racemate. To prepare an ester.

본 발명의 또 다른 목적은 공지기술과는 달리 수분과 접촉시 화재를 유발하는 시약, 유독성 기체를 발생하는 시약, 또는 고압의 수소를 사용하지 않는 안전한 톨테로딘 라세미체의 제조방법을 제공하는 것이다.Another object of the present invention is to provide a method for preparing a safe tolterodine racemate without using a reagent that causes a fire when contacted with moisture, a toxic gas generating reagent, or high-pressure hydrogen, unlike the known art. .

본 발명의 또 다른 목적은 공지기술과는 달리 고압의 반응공정을 사용하지 않으면서도 6-메틸-4-페닐-3,4-디히드로쿠마린으로부터 네 단계의 반응공정만을 거쳐 톨테로딘 라세미체를 제조하는 방법을 제공하는 것이다.Another object of the present invention, unlike the known technology, without using a high-pressure reaction process from the 6-methyl-4-phenyl-3,4-dihydrocoumarin through a four-step reaction process to the tolterodine racemate It is to provide a method of manufacturing.

본 발명의 또 다른 목적은 보다 간편하고 경제적으로 톨테로딘 라세미체를 고순도, 고수율로 제조하는 방법을 제공하는 것이다.Still another object of the present invention is to provide a method for producing tolterodine racemate in high purity and high yield more simply and economically.

본 발명의 또 다른 목적은 톨테로딘 라세미체를 대량으로 제조하기에 적합한 방법을 제공하기 위한 것이다.Another object of the present invention is to provide a method suitable for the preparation of tolterodine racemates in bulk.

본 발명의 상기 및 기타의 목적들은 하기 설명되는 본 발명에 의하여 모두 달성될 수 있다.The above and other objects of the present invention can be achieved by the present invention described below.

본 발명은 톨테로딘 라세미체 및 이의 중간체를 제조하는 방법을 제공한다.The present invention provides a method for preparing tolterodine racemates and intermediates thereof.

본 발명은 다음과 같은 공정에 의하여 하기 화학식 (I)로 표시되는 N,N-디이 소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민(톨테로딘 라세미체)을 제조하는 방법에 관한 것이다: 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 리튬보로히드리드와 반응시켜 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐프로필)-4-메틸페놀을 제조하는 단계, 화학식 (IV)의 화합물을 메탄술포닐 클로라이드 및 트리에틸아민과 반응시켜 화학식 (V)로 표시되는 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르를 제조하는 단계, 화학식 (V)의 화합물을 요오드화염과 N,N-디이소프로필아민과 순차적으로 반응시켜 화학식 (VI)으로 표시되는 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르를 제조하는 단계, 화학식 (VI)의 화합물을 수용성 용매 및 물의 혼합용매에서 알칼리 금속의 수산화염과 반응시켜 톨테로딘 라세미체를 제조하는 단계.The present invention provides N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine represented by the following formula (I) by the following process (tolerodine racemate) A method of preparing a compound of the present invention relates to a method of preparing: 2- (3) represented by formula (IV) by reacting 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by formula (III) with lithium borohydride. Preparing hydroxy-1-phenylpropyl) -4-methylphenol, reacting a compound of formula (IV) with methanesulfonyl chloride and triethylamine to give methanesulphonic acid 3- ( Preparing 2-methanesulfoxy-5-methylphenyl) -3-phenylpropyl ester, the compound of formula (V) is sequentially reacted with an iodide salt and N, N-diisopropylamine, represented by formula (VI) Preparing methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenylester, the compound of formula (VI) Reacting the compound with a hydroxide of an alkali metal in a mixed solvent of an aqueous solvent and water to prepare tolterodine racemate.

본 발명의 바람직한 구체예를 하기 반응식 4에 도시하였다.Preferred embodiments of the invention are shown in Scheme 4 below.

반응식 4Scheme 4

Figure 112006056397066-pat00007
Figure 112006056397066-pat00007

상기 식에서, M은 리튬, 나트륨, 칼륨, 루비듐, 세슘 등의 알칼리금속 또는 암모늄, 테트라에틸암모늄, 테트라부틸암모늄 등의 암모늄이고, M'는 리튬, 나트륨 또는 칼륨과 같은 알칼리금속이다. Wherein M is an alkali metal such as lithium, sodium, potassium, rubidium, cesium or ammonium such as ammonium, tetraethylammonium or tetrabutylammonium, and M 'is an alkali metal such as lithium, sodium or potassium.

또한, 본 발명은 톨테로딘을 제조하기 위한 중간체 화합물인 화학식 (VI)으로 표시되는 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르의 제조방법을 제공한다.The present invention also provides a method for preparing methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenylester represented by the formula (VI) which is an intermediate compound for preparing tolterodine. .

본 발명에 따르면, 톨테로딘 라세미체를 제조하는 과정에서 이의 중간체인 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르를 얻어낼 수 있다. 화학식(IV)로 표시되는 2-(3-히드록시-1-페닐프로필)-4-메틸페놀을 메탄술포닐 클로라이드 및 트리에틸아민과 반응시켜 화학식 (V)로 표시되는 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르를 제조하고, 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르(V)를 요오드화염과 N,N-디이소프로필아민과 순차적으로 반응시키면, 간단하게 화학식 (VI)으로 표시되는 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르를 얻을 수 있다.According to the present invention, it is possible to obtain methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenyl ester as an intermediate thereof in the process of preparing tolterodine racemate. Reaction of 2- (3-hydroxy-1-phenylpropyl) -4-methylphenol represented by formula (IV) with methanesulfonyl chloride and triethylamine to give methanesulphonic acid 3- ( 2-methanesulfoxy-5-methylphenyl) -3-phenylpropyl ester was prepared, and methanesulfonic acid 3- (2-methanesulfoxy-5-methylphenyl) -3-phenylpropyl ester (V) was treated with iodide and N By sequentially reacting with N-diisopropylamine, methanesulfonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenyl ester represented by the general formula (VI) can be obtained.

이하에서, 본 발명을 더욱 상세히 설명한다. In the following, the present invention is described in more detail.

제1단계: 2-(3-히드록시-1-First step: 2- (3-hydroxy-1- 페닐프로필Phenylpropyl )-4-)-4- 메틸페놀(IV)의Of methylphenol (IV) 제조 Produce

반응용매 하에서 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 리튬보로히드리드와 반응시켜 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐프로필)-4-메틸페놀을 제조한다. 2- (3-hydroxy-1) represented by formula (IV) by reacting 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by formula (III) with lithium borohydride under a reaction solvent -Phenylpropyl) -4-methylphenol is prepared.

반응용매는 테트라하이드로푸란, 디이소프로필에테르, 디옥산 등의 에테르류가 바람직하며, 테트라하이드로푸란이 가장 바람직하다. 반응온도는 0℃ 내지 반응용매의 비점이며, 바람직하게는 25 내지 35℃이다. 반응시간은 12시간 내지 36시간 사이이며, 더욱 바람직하게는 18시간 내지 30시간이다. The reaction solvent is preferably ether such as tetrahydrofuran, diisopropyl ether or dioxane, and tetrahydrofuran is most preferred. Reaction temperature is the boiling point of 0 degreeC-a reaction solvent, Preferably it is 25-35 degreeC. The reaction time is between 12 hours and 36 hours, more preferably 18 hours to 30 hours.

리튬보로히드리드는 6-메틸-4-페닐-3,4-디히드로쿠마린(III)에 대하여 1당량 내지 1.5당량 사용되며, 더욱 바람직하게는 1당량 내지 1.05당량 사용된다.Lithium borohydride is used in the amount of 1 to 1.5 equivalents, more preferably 1 to 1.05 equivalents based on 6-methyl-4-phenyl-3,4-dihydrocoumarin (III).

상기한 바와 같은 반응을 통하여 얻어진 2-(3-히드록시-1-페닐프로필)-4-메 틸페놀(IV)은 용매를 감압하여 농축시킨 후 물과 염산을 가하여 수층을 산성으로 만든 후 에틸아세테이트로 추출하고 농축하여 회수할 수 있다. 2- (3-hydroxy-1-phenylpropyl) -4-methylphenol (IV) obtained through the reaction as described above was concentrated under reduced pressure of a solvent, water and hydrochloric acid were added to make the aqueous layer acidic. Extract with acetate and concentrate to recover.

제2단계: Second step: 메탄술포닉산Methanesulfonic acid 3-(2- 3- (2- 메탄술폭시Methane Sulfoxy -5--5- 메틸페닐Methylphenyl )-3-) -3- 페닐프로필에스테르Phenylpropyl Ester (V)의 제조 (V) Preparation

반응용매 하에서 제1단계에서 얻어진 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐프로필)-4-메틸페놀에 메탄술포닐 클로라이드 및 트리에틸아민을 가하여 반응시켜 화학식 (V)로 표시되는 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르를 제조한다. Methanesulfonyl chloride and triethylamine were added to 2- (3-hydroxy-1-phenylpropyl) -4-methylphenol represented by the formula (IV) obtained in the first step under a reaction solvent to react with the formula (V). Methanesulfonic acid 3- (2-methanesulfoxy-5-methylphenyl) -3-phenylpropyl ester represented by is prepared.

반응용매는 테트라하이드로푸란, 디이소프로필에테르, 디옥산 등의 에테르류, 아세토니트릴 등의 니트릴류, 디클로로메탄, 클로로포름, 1,2-디클로로에탄 등의 염화 탄화수소류, 디메틸아세트아미드, 디메틸포름아미드 등의 아미드류로부터 선택하여 사용할 수 있다. 반응온도는 0℃ 내지 35℃이며, 바람직하게는 25 내지 30℃이다. 반응시간은 반응시작 직후부터 2시간 사이이며, 더욱 바람직하게는 40분 내지 1시간이다. Reaction solvents include ethers such as tetrahydrofuran, diisopropyl ether and dioxane, nitriles such as acetonitrile, chlorinated hydrocarbons such as dichloromethane, chloroform and 1,2-dichloroethane, dimethylacetamide and dimethylformamide. It can select from amides, such as these, and can use. Reaction temperature is 0 degreeC-35 degreeC, Preferably it is 25-30 degreeC. The reaction time is between 2 hours immediately after the start of the reaction, more preferably 40 minutes to 1 hour.

메탄술포닐 클로라이드는 2-(3-히드록시-1-페닐프로필)-4-메틸페놀(IV)에 대하여 2당량 내지 3당량 사용되며, 바람직하게는 2.2당량 사용된다.Methanesulfonyl chloride is used in the amount of 2 to 3 equivalents, preferably 2.2 equivalents, relative to 2- (3-hydroxy-1-phenylpropyl) -4-methylphenol (IV).

트리에틸아민은 메탄술포닐 클로라이드에 대하여 1당량 내지 1.2당량 사용되며, 바람직하게는 1.1당량 사용된다.Triethylamine is used in the amount of 1 to 1.2 equivalents based on methanesulfonyl chloride, preferably 1.1 equivalents.

상기한 바와 같은 반응을 통하여 얻어진 화학식 (V)로 표시되는 화합물은 용매를 감압하여 농축시킨 후 에틸아세테이트와 물을 가하여 추출한 후 세척하고 농 축하여 회수할 수 있다. The compound represented by the formula (V) obtained through the reaction as described above can be recovered by concentrating the solvent under reduced pressure, extracting by adding ethyl acetate and water, washing and concentrating.

제3단계: Step 3: 메탄술포닉산Methanesulfonic acid 2-(3- 2- (3- 디이소프로필아미노Diisopropylamino -1--One- 페닐프로필Phenylpropyl )-4-)-4- 메틸페닐에스테르Methylphenyl ester ( ( VIVI )의 제조Manufacturing

반응용매 하에서 제2단계에서 얻어진 화학식 (V)로 표시되는 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르에 요오드화염과 N,N-디이소프로필아민을 순차적으로 반응시켜 화학식 (VI)으로 표시되는 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르를 제조한다. Iodine salt and N, N-diisopropylamine were added to methanesulphonic acid 3- (2-methanesulfoxy-5-methylphenyl) -3-phenylpropyl ester represented by the formula (V) obtained in the second step under a reaction solvent. By sequentially reacting, methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenyl ester represented by the formula (VI) is prepared.

반응용매는 테트라하이드로푸란, 디이소프로필에테르, 디옥산 등의 에테르류, 아세토니트릴 등의 니트릴류, 디클로로메탄, 클로로포름, 1,2-디클로로에탄 등의 염화 탄화수소류, 디메틸아세트아미드, 디메틸포름아미드 등의 아미드류로부터 선택하여 사용할 수 있으며, 이 중에서 아세토니트릴이 가장 바람직하다. 반응용매의 양은 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르(V) 1g에 대하여 5ml 내지 20ml의 비율로 사용되며, 바람직하게는 7ml 내지 10ml의 비율로 사용된다. Reaction solvents include ethers such as tetrahydrofuran, diisopropyl ether and dioxane, nitriles such as acetonitrile, chlorinated hydrocarbons such as dichloromethane, chloroform and 1,2-dichloroethane, dimethylacetamide and dimethylformamide. It can select from amides, such as these, and can use acetonitrile among them. The amount of the reaction solvent is used in a ratio of 5 ml to 20 ml with respect to 1 g of methanesulphonic acid 3- (2-methanesulfoxy-5-methylphenyl) -3-phenylpropyl ester (V), preferably in a ratio of 7 ml to 10 ml. Used.

요오드화염과의 반응시간은 3시간 내지 10시간이며, 더욱 바람직하게는 5시간 내지 7시간이다. N,N-디이소프로필아민과의 반응시간은 12시간 내지 36시간이며, 더욱 바람직하게는 20시간 내지 26시간이다. 반응온도는 60℃ 내지 반응용매의 비점이다. The reaction time with the iodide flame is 3 hours to 10 hours, more preferably 5 hours to 7 hours. The reaction time with N, N-diisopropylamine is 12 hours to 36 hours, more preferably 20 hours to 26 hours. The reaction temperature is from 60 ° C. to the boiling point of the reaction solvent.

요오드화염은 요오드화리튬, 요오드화나트륨, 요오드화칼륨, 요오드화루비듐, 요오드화세슘 등과 같은 알칼리 금속의 요오드화물 또는 요오드화암모늄, 요오 드화테트라에틸암모늄, 요오드화테트라부틸암모늄 등과 같은 암모늄의 요오드화물이 사용된다. 요오드화염은 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르(V)에 대하여 1.1당량 내지 2당량 사용되며, 바람직하게는 1.5당량 사용된다.As the iodide, iodide of an alkali metal such as lithium iodide, sodium iodide, potassium iodide, rubidium iodide, cesium iodide or the like or an iodide of ammonium such as ammonium iodide, tetraethylammonium iodide, tetrabutylammonium iodide and the like is used. Iodide is used in the amount of 1.1 to 2 equivalents, preferably 1.5 equivalents, to methanesulphonic acid 3- (2-methanesulfoxy-5-methylphenyl) -3-phenylpropylester (V).

N,N-디이소프로필아민의 함량은 사용되는 반응용매 부피의 0.5 내지 1배이며, 바람직하게는 0.7배인 것이다. The content of N, N-diisopropylamine is 0.5 to 1 times the volume of the reaction solvent used, preferably 0.7 times.

상기한 바와 같은 반응을 통하여 얻어진 화학식 (VI)으로 표시되는 화합물은 용매를 감압하여 농축시킨 후 에틸아세테이트와 물을 가하여 추출한 후 세척하고 농축하여 회수할 수 있다. The compound represented by the formula (VI) obtained through the reaction as described above can be recovered by concentrating the solvent under reduced pressure, extracting by adding ethyl acetate and water, washing and concentrating.

제4단계: N,N-Fourth Step: N, N- 디이소프로필Diisopropyl -3-(2--3- (2- 하이드록시Hydroxy -5--5- 메틸페닐Methylphenyl )-3-) -3- 페닐프로판아민(I)의Of phenylpropanamine (I) 제조 Produce

반응용매 하에서 화학식 (VI)으로 표시되는 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르에 수산화염을 첨가하여 반응시켜 화학식 (I)로 표시되는 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민을 제조한다.N represented by the formula (I) by reacting with methanesulfonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenyl ester represented by the formula (VI) under a reaction solvent by adding a hydroxide salt, Prepare N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine.

반응용매는 수용성 용매와 물의 혼합용매가 사용된다. 수용성 용매는 테트라하이드로푸란, 아세토니트릴, 에탄올, 메탄올로부터 선택하여 사용할 수 있으며, 이 중에서 메탄올이 가장 바람직하다. 사용되는 수용성 용매와 물의 부피비는 10:1 내지 1:2이며 바람직하게는 3:1 내지 1:1이다. As the reaction solvent, a mixed solvent of an aqueous solvent and water is used. The water-soluble solvent can be selected from tetrahydrofuran, acetonitrile, ethanol and methanol, of which methanol is most preferred. The volume ratio of the water-soluble solvent and water used is 10: 1 to 1: 2 and preferably 3: 1 to 1: 1.

수산화염은 수산화리튬, 수산화나트륨, 수산화칼륨으로부터 선택되는 알칼리 금속의 수산화물이 사용된다. 수산화염의 양은 반응에 사용되는 화학식 (VI)으로 표시되는 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르에 대하여 2당량 내지 10당량 사용되며 바람직하게는 3당량 내지 5당량 사용된다. As the hydroxide, an alkali metal hydroxide selected from lithium hydroxide, sodium hydroxide and potassium hydroxide is used. The amount of hydroxide is used in the amount of 2 to 10 equivalents based on methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenyl ester represented by the formula (VI) used in the reaction, preferably 3 to 5 equivalents are used.

바람직한 반응온도는 혼합용매의 비점이다. 반응시간은 3시간 내지 20시간 이며, 더욱 바람직하게는 6시간 내지 10시간이다. Preferred reaction temperatures are the boiling points of the mixed solvents. The reaction time is 3 hours to 20 hours, more preferably 6 hours to 10 hours.

상기한 바와 같은 반응을 통하여 얻어진 화학식 (I)로 표시되는 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민은 용매를 감압하여 유기용매를 제거한 후 염산으로 수층의 pH를 8로 맞춘 후 에틸아세테이트로 추출하여 회수할 수 있다. N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine represented by the formula (I) obtained through the reaction as described above was removed under reduced pressure to remove the organic solvent. After adjusting the pH of the aqueous layer to 8 with hydrochloric acid it can be recovered by extraction with ethyl acetate.

상기한 바와 같은 4단계의 반응 공정으로 이루어지는 본 발명에 따른 제조방법은 대량합성공정에서 사용하기 어려운 시약이나 고압 공정을 사용하지 않음으로써 합성공정을 용이하게 하고, 페놀기의 보호기 도입반응을 별도의 공정없이 기존 공정에 포함하여 수행함으로써 합성공정을 단축할 수 있다. The production method according to the present invention consisting of a four-step reaction process as described above facilitates the synthesis process by not using a reagent or a high pressure process that is difficult to use in a mass synthesis process, and separates the reaction of introducing a protecting group into a phenol group. The synthesis process can be shortened by performing the process without including the process.

본 발명은 하기의 실시예에 의하여 보다 더 잘 이해될 수 있으며, 하기의 실시예는 본 발명을 예시하기 위한 것이며 첨부된 특허청구범위에 의하여 한정되는 보호범위를 제한하고자 하는 것은 아니다.The invention can be better understood by the following examples, which are intended to illustrate the invention and are not intended to limit the scope of protection defined by the appended claims.

실시예Example

실시예Example 1 : 2-(3-히드록시-1- 1: 2- (3-hydroxy-1- 페닐프로필Phenylpropyl )-4-)-4- 메틸페놀(IV)의Of methylphenol (IV) 제조 Produce

6-메틸-4-페닐-3,4-디히드로쿠마린 136.2g (571mmol)을 테트라히드로퓨란 400ml에 용해시킨 후 빙냉하에서 리튬보로히드리드 13.1g (571mmol)을 서서히 가하고 반응용액의 온도를 실온으로 올렸다. 반응용액을 24시간 동안 교반한 후 빙냉하에서 증류수를 조금씩 가하고 감압 하에서 용매를 제거하였다. 얻어진 잔사에 증류수 200ml와 진한 염산 20ml를 가하여 에틸아세테이트로 추출하고 증류수 400ml로 세척한 후 무수 황산 마그네슘으로 건조시켰다. 얻어진 유기층을 감압 하에서 농축시켜 고체상의 2-(3-히드록시-1-페닐프로필)-4-메틸페놀 122.13g (수율 88%)을 얻었다.After dissolving 136.2 g (571 mmol) of 6-methyl-4-phenyl-3,4-dihydrocoumarin in 400 ml of tetrahydrofuran, 13.1 g (571 mmol) of lithium borohydride was slowly added under ice-cooling, and the reaction solution was allowed to stand at room temperature. Raised to After stirring the reaction solution for 24 hours, distilled water was added little by little under ice-cooling, and the solvent was removed under reduced pressure. To the obtained residue was added 200 ml of distilled water and 20 ml of concentrated hydrochloric acid, extracted with ethyl acetate, washed with 400 ml of distilled water and dried over anhydrous magnesium sulfate. The obtained organic layer was concentrated under reduced pressure to obtain 122.13 g (yield 88%) of solid 2- (3-hydroxy-1-phenylpropyl) -4-methylphenol.

1H NMR (CDCl3) δ=2.18 (s, 3H), 2.19 (m, 1H), 2.32 (m, 1H), 3.53 (m, 1H), 3.72 (m, 1H), 4.52 (q, 1H), 6.68 (d, 1H), 6.85 (m, 2H), 7.17 (m, 1H), 7.27 (m, 4H) 1 H NMR (CDCl 3 ) δ = 2.18 (s, 3H), 2.19 (m, 1H), 2.32 (m, 1H), 3.53 (m, 1H), 3.72 (m, 1H), 4.52 (q, 1H) , 6.68 (d, 1H), 6.85 (m, 2H), 7.17 (m, 1H), 7.27 (m, 4H)

실시예Example 2 :  2 : 메탄술포닉산Methanesulfonic acid 3-(2- 3- (2- 메탄술폭시Methane Sulfoxy -5--5- 메틸페닐Methylphenyl )-3-) -3- 페닐프로필에스테르(V)의Of phenylpropyl ester (V) 제조 Produce

실시예 1에서 얻어진 2-(3-히드록시-1-페닐프로필)-4-메틸페놀 115.6g (477mmol)을 디클로로메탄 500ml에 용해시킨 후 빙냉하에서 트리에틸아민 115.86g (1145mmol)과 메탄술포닐 클로라이드 120.17g (1049mmol)을 순차적으로 가하였다. 반응용액의 온도를 실온으로 올린 후 1시간동안 교반하고 증류수 1500ml로 세척하여 무수 황산 마그네슘으로 건조시켰다. 얻어진 유기층을 감압 하에서 농축시켜 오일상의 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르 190.08g (수율 100%)을 얻었다.115.6 g (477 mmol) of 2- (3-hydroxy-1-phenylpropyl) -4-methylphenol obtained in Example 1 was dissolved in 500 ml of dichloromethane, and then 115.86 g (1145 mmol) of triethylamine and methanesulfonyl under ice-cooling. 120.17 g (1049 mmol) of chloride were added sequentially. After raising the temperature of the reaction solution to room temperature, the mixture was stirred for 1 hour, washed with 1500 ml of distilled water, and dried over anhydrous magnesium sulfate. The obtained organic layer was concentrated under reduced pressure to give 190.08 g (yield 100%) of oily methanesulphonic acid 3- (2-methanesulfoxy-5-methylphenyl) -3-phenylpropyl ester.

1H NMR (CDCl3) δ=2.27 (s, 3H), 2.47 (q, 2H), 2.97 (s, 3H), 3.01 (s, 3H), 4.18 (m, 2H), 4.56 (t, 1H), 7.04 (dd, 1H), 7.12 (d, 1H), 7.28 (m, 6H) 1 H NMR (CDCl 3 ) δ = 2.27 (s, 3H), 2.47 (q, 2H), 2.97 (s, 3H), 3.01 (s, 3H), 4.18 (m, 2H), 4.56 (t, 1H) , 7.04 (dd, 1H), 7.12 (d, 1H), 7.28 (m, 6H)

실시예Example 3 :  3: 메탄술포닉산Methanesulfonic acid 2-(3- 2- (3- 디이소프로필아미노Diisopropylamino -1--One- 페닐프로필Phenylpropyl )-4-메틸페닐에스테르() -4-methylphenyl ester ( VI)의VI) 제조 Produce

실시예 2에서 얻어진 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르 190.08g (477mmol)과 요오드화칼륨 118.78g (715mmol)을 아세토니트릴 1000ml에 용해한 후 6시간 동안 환류하였다. 반응용액의 온도를 실온으로 냉각한 후 N,N-디이소프로필아민 700ml를 가하고 다시 24시간 동안 환류하였다. 반응용액의 온도를 실온으로 냉각한 후 감압 하에서 용매를 제거하고 에틸아세테이트 600ml를 가하여 증류수 1500ml로 세척하였다. 얻어진 유기층을 무수 황산 마그네슘으로 건조시키고 감압 하에서 농축하여 오일상의 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르 190.29g (수율 99%)을 얻었다.Methanesulphonic acid 3- (2-methanesulfoxy-5-methylphenyl) -3-phenylpropyl ester 190.08 g (477 mmol) and 118.78 g (715 mmol) of potassium iodide obtained in Example 2 were dissolved in 1000 ml of acetonitrile for 6 hours. It was refluxed. After the reaction solution was cooled to room temperature, 700 ml of N, N-diisopropylamine was added thereto, and the mixture was refluxed for 24 hours. After the reaction solution was cooled to room temperature, the solvent was removed under reduced pressure, and 600 ml of ethyl acetate was added thereto, followed by washing with 1500 ml of distilled water. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 190.29 g (yield 99%) of oily methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenyl ester.

1H NMR (CDCl3) δ=0.91 (m, 12H), 2.11 (m, 2H), 2.29 (m, 5H), 2.86 (s, 3H), 2.96 (m, 2H), 4.33 (t, 1H), 7.00 (dd, 1H), 7.16 (m, 1H), 7.27 (m, 6H) 1 H NMR (CDCl 3 ) δ = 0.91 (m, 12H), 2.11 (m, 2H), 2.29 (m, 5H), 2.86 (s, 3H), 2.96 (m, 2H), 4.33 (t, 1H) , 7.00 (dd, 1H), 7.16 (m, 1H), 7.27 (m, 6H)

실시예Example 4 : N,N- 4: N, N- 디이소프로필Diisopropyl -3-(2--3- (2- 하이드록시Hydroxy -5--5- 메틸페닐Methylphenyl )-3-) -3- 페닐프로판아민의Of phenylpropanamine 제조 Produce

실시예 3에서 얻어진 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르 190.2g (471mmol)을 메탄올과 물의 2:1 혼합용매 1000ml에 용 해시키고 수산화나트륨 94.2g (2350mmol)을 가했다. 반응용액을 10시간 동안 환류시킨 후 반응용액의 온도를 실온으로 냉각시키고 용매를 감압 하에서 제거하여 반응용액의 부피를 1/3로 농축하였다. 진한 염산으로 수층의 pH를 8로 맞춘 후 에틸아세테이트 600mL로 추출하였다. 얻어진 유기층을 무수 황산 마그네슘으로 건조시키고 감압 하에서 농축하여 오일상의 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민 152.95g (수율 99%)을 얻었다.190.2 g (471 mmol) of methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenyl ester obtained in Example 3 were dissolved in 1000 ml of a 2: 1 mixed solvent of methanol and water, and sodium hydroxide 94.2 g (2350 mmol) was added. The reaction solution was refluxed for 10 hours, the temperature of the reaction solution was cooled to room temperature, the solvent was removed under reduced pressure, and the volume of the reaction solution was concentrated to 1/3. The pH of the aqueous layer was adjusted to 8 with concentrated hydrochloric acid, and extracted with 600 mL of ethyl acetate. The resulting organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give 152.95 g (yield 99%) of oily N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine. .

1H NMR (CDCl3) δ=1.08 (dd, 12H), 2.11 (m, 3H), 2.11 (m, 1H), 2.36 (m, 2H), 2.73 (m, 1H), 3.24 (m, 2H), 4.47 (d, 1H), 6.55 (s, 1H), 6.82 (m, 2H), 7.22 (m, 2H), 7.31 (m, 4H) 1 H NMR (CDCl 3 ) δ = 1.08 (dd, 12H), 2.11 (m, 3H), 2.11 (m, 1H), 2.36 (m, 2H), 2.73 (m, 1H), 3.24 (m, 2H) , 4.47 (d, 1H), 6.55 (s, 1H), 6.82 (m, 2H), 7.22 (m, 2H), 7.31 (m, 4H)

본 발명은 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 리튬보로히드리드와 반응시켜 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐프로필)-4-메틸페놀을 제조하고, 이를 메탄술포닐 클로라이드 및 트리에틸아민을 반응시켜 화학식 (V)로 표시되는 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르를 제조하고, 이를 요오드화염과 N,N-디이소프로필아민을 순차적으로 반응시켜 화학식 (VI)으로 표시되는 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르를 제조하고, 이를 수용성용매 및 물의 혼합용매에서 수산화염을 반응시켜 화학식 (I)로 표시되는 N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민을 고수율로 용이하게 제조하는 방법을 제공하는 효과 를 가진다. The present invention relates to 2- (3-hydroxy-1) represented by formula (IV) by reacting 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by formula (III) with lithium borohydride. -Phenylpropyl) -4-methylphenol, which is reacted with methanesulfonyl chloride and triethylamine to give methanesulphonic acid 3- (2-methanesuloxy-5-methylphenyl) -3 represented by the formula (V). -Phenylpropylester, which is reacted sequentially with an iodide salt and N, N-diisopropylamine to form methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) represented by the formula (VI) N-N-diisopropyl-3- (2-hydroxy-5-methylphenyl)-represented by the formula (I) is prepared by reacting a 4-hydroxyphenyl salt with a water-soluble solvent and a mixed solvent of water. It has the effect of providing a method for easily preparing 3-phenylpropanamine in high yield.

화학식 (I)로 표시되는 톨테로딘 라세미체를 제조하는 방법에 관련된 선행기술의 경우 수분과 접촉시 화재를 유발하는 시약, 유독성 기체를 발생시키는 시약, 또는 고압의 수소를 사용하면서도 반응공정이 길거나 어려워 실제 대량 공정에 적용하기 어렵다는 문제가 있었다. 그러나 본 발명은 상기한 바와 같은 위험하거나 유독성 시약을 사용하지 않으며, 또한 고압의 반응공정을 사용하지 않으면서도 반응공정이 단축된 새로운 공정으로 고품질 및 고수율로 톨테로딘 라세미체를 제조할 수 있다는 장점을 갖는다.The prior art related to the process for preparing tolterodine racemate represented by the formula (I) has a long reaction process using a reagent which causes a fire upon contact with moisture, a reagent which generates toxic gases, or high pressure hydrogen. There was a problem that it was difficult to apply to the actual bulk process. However, the present invention does not use dangerous or toxic reagents as described above, and can produce tolterodine racemate with high quality and high yield with a new process with a shortened reaction process without using a high pressure reaction process. Has an advantage.

본 발명의 단순한 변형 내지 변경은 이 분야의 통상의 지식을 가진 자에 의하여 용이하게 이해될 수 있으며, 이러한 변형이나 변경은 모두 본 발명의 영역에 포함되는 것으로 볼 수 있다.Simple modifications and variations of the present invention can be readily understood by those skilled in the art, and all such variations or modifications can be considered to be included within the scope of the present invention.

Claims (7)

하기 화학식 (III)으로 표시되는 6-메틸-4-페닐-3,4-디히드로쿠마린을 리튬보로히드리드와 반응시켜 하기 화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐프로필)-4-메틸페놀을 제조하는 제1단계, 6-methyl-4-phenyl-3,4-dihydrocoumarin represented by the following formula (III) is reacted with lithium borohydride to form 2- (3-hydroxy-1- represented by the following formula (IV) First step of preparing phenylpropyl) -4-methylphenol, 2-(3-히드록시-1-페닐프로필)-4-메틸페놀(IV)을 메탄술포닐 클로라이드 및 트리에틸아민과 반응시켜 하기 화학식 (V)로 표시되는 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르를 제조하는 제2단계, Methanesulfonic acid 3- (2-methane represented by the following general formula (V) by reacting 2- (3-hydroxy-1-phenylpropyl) -4-methylphenol (IV) with methanesulfonyl chloride and triethylamine A second step of preparing sulfoxy-5-methylphenyl) -3-phenylpropyl ester, 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르(V)를 요오드화염과 N,N-디이소프로필아민을 순차적으로 반응시켜 하기 화학식 (VI)으로 표시되는 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르를 제조하는 제3단계, 및Methanesulfonic acid 3- (2-methanesulfoxy-5-methylphenyl) -3-phenylpropyl ester (V) is reacted sequentially with an iodide salt and N, N-diisopropylamine, and is represented by the following general formula (VI) A third step of preparing methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenylester, and 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르(VI)를 알칼리 금속의 수산화물과 반응시키는 제4단계:Fourth step of reacting methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenylester (VI) with a hydroxide of an alkali metal: 로 이루어지는 하기 화학식 (I)로 표시되는 (N,N-디이소프로필-3-(2-하이드록시-5-메틸페닐)-3-페닐프로판아민 (톨테로딘 라세미체)의 제조 방법.A process for producing (N, N-diisopropyl-3- (2-hydroxy-5-methylphenyl) -3-phenylpropanamine (tolerodine racemate) represented by the following general formula (I).
Figure 112006056397066-pat00008
Figure 112006056397066-pat00009
Figure 112006056397066-pat00010
Figure 112006056397066-pat00008
Figure 112006056397066-pat00009
Figure 112006056397066-pat00010
Figure 112006056397066-pat00011
Figure 112006056397066-pat00012
Figure 112006056397066-pat00011
Figure 112006056397066-pat00012
화학식 (IV)로 표시되는 2-(3-히드록시-1-페닐프로필)-4-메틸페놀을 메탄술포닐 클로라이드 및 트리에틸아민과 반응시켜 화학식 (V)로 표시되는 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르를 제조하는 단계, 및 Reaction of 2- (3-hydroxy-1-phenylpropyl) -4-methylphenol represented by the formula (IV) with methanesulfonyl chloride and triethylamine to give the methanesulphonic acid 3- ( Preparing 2-methanesulfoxy-5-methylphenyl) -3-phenylpropyl ester, and 메탄술포닉산 3-(2-메탄술폭시-5-메틸페닐)-3-페닐프로필에스테르(V)를 요오드화염과 N,N-디이소프로필아민을 순차적으로 반응시켜 화학식 (VI)으로 표시되는 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르를 제조하는 단계:Methane represented by the formula (VI) by sequentially reacting methanesulphonic acid 3- (2-methanesulfoxy-5-methylphenyl) -3-phenylpropylester (V) with an iodide salt and N, N-diisopropylamine Preparation of sulfonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenylester: 로 이루어지는 톨테로딘 중간체, 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르(VI)의 제조 방법.The manufacturing method of the tolterodine intermediate which consists of methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenyl ester (VI).
Figure 112006056397066-pat00013
Figure 112006056397066-pat00014
Figure 112006056397066-pat00015
Figure 112006056397066-pat00013
Figure 112006056397066-pat00014
Figure 112006056397066-pat00015
제1항에 있어서, 상기 알칼리 금속의 수산화물이 수산화리튬, 수산화나트륨, 또는 수산화칼륨인 것을 특징으로 하는 톨테로딘 라세미체의 제조방법.The method for producing tolterodine racemate according to claim 1, wherein the alkali metal hydroxide is lithium hydroxide, sodium hydroxide or potassium hydroxide. 제1항에 있어서, 상기 제4단계는 테트라하이드로푸란, 아세토니트릴, 에탄올, 및 메탄올로 이루어지는 군으로부터 선택되는 수용성 용매와 물의 혼합 용매 하에서 실시되는 것을 특징으로 하는 톨테로딘 라세미체의 제조방법.The method of claim 1, wherein the fourth step is performed under a mixed solvent of water-soluble solvent and water selected from the group consisting of tetrahydrofuran, acetonitrile, ethanol, and methanol. 제1항 또는 제2항에 있어서, 상기 요오드화염이 요오드화리튬, 요오드화나트륨, 요오드화칼륨, 요오드화루비듐, 요오드화세슘과 같은 알칼리 금속의 요오드화물; 또는 요오드화암모늄, 요오드화테트라에틸암모늄, 요오드화테트라부틸암모늄과 같은 암모늄의 요오드화물인 것을 특징으로 하는 톨테로딘 라세미체 또는 이의 중 간체의 제조방법.3. An iodide of an alkali metal as claimed in claim 1 or 2, wherein the salt of iodide is lithium iodide, sodium iodide, potassium iodide, rubidium iodide, cesium iodide; Or ammonium iodide such as ammonium iodide, tetraethylammonium iodide, tetrabutylammonium iodide, or a method for producing tolterodine racemate or intermediate thereof. 제1항 또는 제2항에 있어서, 상기 메탄술포닉산 2-(3-디이소프로필아미노-1-페닐프로필)-4-메틸페닐에스테르(VI)를 제조하는 단계는 테트라하이드로푸란, 디이소프로필에테르, 디옥산과 같은 에테르류, 아세토니트릴과 같은 니트릴류, 디클로로메탄, 클로로포름, 1,2-디클로로에탄과 같은 염화 탄화수소류, 디메틸아세트아미드, 디메틸포름아미드과 같은 아미드류로부터 선택되는 반응용매 하에서 실시되는 것을 특징으로 하는 톨테로딘 라세미체 또는 이의 중간체의 제조방법.The method of claim 1 or 2, wherein the methanesulphonic acid 2- (3-diisopropylamino-1-phenylpropyl) -4-methylphenyl ester (VI) is prepared by using tetrahydrofuran, diisopropyl ether. , A solvent such as dioxane, nitriles such as acetonitrile, dichloromethane, chloroform, chlorinated hydrocarbons such as 1,2-dichloroethane, amides such as dimethylacetamide, and dimethylformamide. Method for producing tolterodine racemates or intermediates thereof, characterized in that. 제6항에 있어서, 상기 반응용매가 아세토니트릴인 것을 특징으로 하는 톨테로딘 라세미체 또는 이의 중간체의 제조방법.7. The method for producing tolterodine racemate or intermediate thereof according to claim 6, wherein the reaction solvent is acetonitrile.
KR1020060074233A 2006-08-07 2006-08-07 Method of preparing racemic tolterodine and its intermediate KR100717361B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060074233A KR100717361B1 (en) 2006-08-07 2006-08-07 Method of preparing racemic tolterodine and its intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060074233A KR100717361B1 (en) 2006-08-07 2006-08-07 Method of preparing racemic tolterodine and its intermediate

Publications (1)

Publication Number Publication Date
KR100717361B1 true KR100717361B1 (en) 2007-05-11

Family

ID=38270494

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060074233A KR100717361B1 (en) 2006-08-07 2006-08-07 Method of preparing racemic tolterodine and its intermediate

Country Status (1)

Country Link
KR (1) KR100717361B1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5382600A (en) 1988-01-22 1995-01-17 Pharmacia Aktiebolag 3,3-diphenylpropylamines and pharmaceutical compositions thereof
KR20020062669A (en) * 1999-12-30 2002-07-26 파마시아 에이비 Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process
EP1584621A1 (en) 2004-03-30 2005-10-12 Dipharma S.p.A. A process for the preparation of tolterodine and intermediates thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5382600A (en) 1988-01-22 1995-01-17 Pharmacia Aktiebolag 3,3-diphenylpropylamines and pharmaceutical compositions thereof
KR20020062669A (en) * 1999-12-30 2002-07-26 파마시아 에이비 Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process
EP1584621A1 (en) 2004-03-30 2005-10-12 Dipharma S.p.A. A process for the preparation of tolterodine and intermediates thereof

Similar Documents

Publication Publication Date Title
US6822119B1 (en) Process for the preparation of tolterodine
WO2009037569A2 (en) An improved process for the preparation of fesoterodine
EP2349976B1 (en) A process for producing (s)-3-[(1-dimethylamino)ethyl]phenyl-n-ethyl-n-methyl-carbamate via novel intermediates
EP2606030B1 (en) Process for the preparation of tapentadol
US8552219B2 (en) Process for preparing L-phenyl-3-dimethylaminopropane derivative
AU2017200463A1 (en) The process for the preparation of metaraminol
WO2007026373A2 (en) Process for preparing rivastigmine
US9085509B2 (en) Process for preparing fesoterodine
KR100717361B1 (en) Method of preparing racemic tolterodine and its intermediate
JP6459852B2 (en) Method for producing ether compound
WO2012089177A1 (en) Method of producing (2r,3r)-na-dimethyl-3-(3-hydroxyphenyi)-2-methylpentylamine (tapentadol)
US7473805B2 (en) Process for obtaining tolterodine
WO2009084037A2 (en) Novel process for preparation of o-desmethylvenlafaxine
KR100686351B1 (en) Method of preparing racemic tolterodine
KR100915551B1 (en) Process for the efficient preparation of 3-hydroxy pyrrolidine and derivatives thereof
WO2011145019A1 (en) Improved process for diphenylpropylamine derivatives
KR101260832B1 (en) Processes for preparing tolterodine or its salt and synthetic intermediates
JPWO2006123672A1 (en) Method for producing amino alcohol derivative having biphenyl group
KR101465777B1 (en) Novel Process for Preparing (+)-Polyoxamic acid
CZ293791B6 (en) Process for preparing N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropyl amine in racemic or optically active form thereof
US7390926B2 (en) Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3
ES2537378T3 (en) A process to prepare Fesoterodina
AU2002321696A1 (en) Process for the preparation of tolterodine
JP2016536367A (en) A novel intermediate of tapentadol
CZ2003531A3 (en) Process for preparing (R)-N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropylamine

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120510

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20130430

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee